Brazil's National Health Surveillance Agency (Anvisa) has approved the use of the drug donanemabe to slow the progression of ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

No neurofibrillary tangles or amyloid plaques were found in the parenchyma ... magnetic gait and hypertonia of the extremities, treatment with dexamethasone (2 × 4 mg/day) was started.

The publication, titled N-Acetylcysteine for hereditary cystatin C amyloid angiopathy (HCCAA), a nonrandomised clinical trial, details a new treatment approach for HCCAA, a rare and fatal genetic ...

Histological examination shows amyloid-laden vessels and the appearance ... appears to derive a beneficial effect from corticosteroid treatment. This effect could be dependant on the pathological ...

Knight says that the method of transmission that Collinge identified is “extremely unusual,” and there’s no evidence that Alzheimer’s can spread through medical procedures used today. He also conceded ...

In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments.

investigated the relationship between anticoagulant use and the location and etiology of intracerebral hemorrhage (ICH), focusing on whether hypertensive microangiopathy or cerebral amyloid angiopathy ...